Association of subpleural ground-glass opacities with respiratory failure and RNAemia in COVID-19

[1]  Y. Morinaga,et al.  Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection , 2022, Viruses.

[2]  Y. Morinaga,et al.  Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure , 2022, Frontiers in Immunology.

[3]  A. Elmokadem,et al.  Comparison of chest CT severity scoring systems for COVID-19 , 2022, European Radiology.

[4]  Hisashi Ishii,et al.  Comparison of semiquantitative chest CT scoring systems to estimate severity in coronavirus disease 2019 (COVID-19) pneumonia , 2022, European Radiology.

[5]  Inyoul Y. Lee,et al.  Multiple early factors anticipate post-acute COVID-19 sequelae , 2022, Cell.

[6]  A. Rubinowitz,et al.  COVID-19 ARDS: a review of imaging features and overview of mechanical ventilation and its complications , 2021, Emergency Radiology.

[7]  H. Tani,et al.  SARS‐CoV‐2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID‐19 , 2021, Journal of medical virology.

[8]  N. Tachikawa,et al.  On-admission SARS-CoV-2 RNAemia as a single potent predictive marker of critical condition development and mortality in COVID-19 , 2021, PloS one.

[9]  E. Thunnissen,et al.  COVID‐19: Histopathological correlates of imaging patterns on chest computed tomography , 2021, Respirology.

[10]  Shun-Fa Yang,et al.  Respiratory care for the critical patients with 2019 novel coronavirus , 2021, Respiratory Medicine.

[11]  E. Sprecher,et al.  Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers. , 2021, JAMA.

[12]  Paul J. Hung,et al.  SARS-CoV-2 RNAemia Predicts Clinical Deterioration and Extrapulmonary Complications from COVID-19 , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Raoof,et al.  The Usefulness of Chest CT Imaging in Patients With Suspected or Diagnosed COVID-19 , 2021, Chest.

[14]  P. Taylor,et al.  Neutralizing monoclonal antibodies for treatment of COVID-19 , 2021, Nature Reviews Immunology.

[15]  S. Raoof,et al.  The Usefulness of Chest CT Imaging in Patients With Suspected or Diagnosed COVID-19 , 2021, Chest.

[16]  A. Imamura,et al.  An analysis of the radiological factors associated with respiratory failure in COVID-19 pneumonia and the CT features among different age categories , 2021, Japanese Journal of Radiology.

[17]  A. Gholamrezanezhad,et al.  COVID-19 or non-COVID viral pneumonia: How to differentiate based on the radiologic findings? , 2020, World journal of radiology.

[18]  E. van Nood,et al.  Temporal Kinetics of RNAemia and Associated Systemic Cytokines in Hospitalized COVID-19 Patients , 2020, bioRxiv.

[19]  H. Tani,et al.  SARS-CoV-2 RNAemia with higher nasopharyngeal viral load is strongly associated with severity and mortality in patients with COVID-19 , 2020, medRxiv.

[20]  K. Mertz,et al.  Lethal COVID-19: Radiologic-Pathologic Correlation of the Lungs , 2020, Radiology. Cardiothoracic imaging.

[21]  H. Rajebi,et al.  Predictive value of CT in the short-term mortality of Coronavirus Disease 2019 (COVID-19) pneumonia in nonelderly patients: A case-control study , 2020, European Journal of Radiology.

[22]  Zhi Mao,et al.  Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis , 2020, Critical Care.

[23]  C. Stroszczynski,et al.  Can CT performed in the early disease phase predict outcome of patients with COVID 19 pneumonia? Analysis of a cohort of 64 patients from Germany , 2020, European Journal of Radiology.

[24]  N. Ceylan,et al.  The novel coronavirus pneumonia (COVID-19): a pictorial review of chest CT features. , 2020, Diagnostic and interventional radiology.

[25]  C. Catalano,et al.  Chest CT score in COVID-19 patients: correlation with disease severity and short-term prognosis , 2020, European Radiology.

[26]  Zhifeng Liu,et al.  The role of chest CT quantitative pulmonary inflammatory index in the evaluation of the course and treatment outcome of COVID-19 pneumonia , 2020, Scientific Reports.

[27]  Sanjiv Sharma,et al.  CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients , 2020, European Radiology.

[28]  Nicola Sverzellati,et al.  Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia , 2020, Radiology.

[29]  C. Eastin,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The Journal of Emergency Medicine.

[30]  Jun Liu,et al.  Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study. , 2020, AJR. American journal of roentgenology.

[31]  Jiyuan Zhang,et al.  Pathological findings of COVID-19 associated with acute respiratory distress syndrome , 2020, The Lancet Respiratory Medicine.

[32]  C. Zheng,et al.  Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia , 2020, Radiology.

[33]  C. Zheng,et al.  Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19) , 2020 .

[34]  H. Muramatsu,et al.  A case of wild-type transthyretin amyloidosis associated with organizing pneumonia , 2017, Journal of rural medicine : JRM.

[35]  T. Mimori,et al.  HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody. , 2011, Respiratory medicine.

[36]  N. Müller,et al.  Fleischner Society: glossary of terms for thoracic imaging. , 2008, Radiology.

[37]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[38]  W. Kofman,et al.  On the usefulness of , 1999 .